• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过药剂师主导的患者教育提高心力衰竭患者的用药依从性:一项基于信息、动机和行为技能的机制性研究方案

Improving Medication Adherence in Heart Failure Through Pharmacist-Led Patient Education: Protocol for a Mechanism-Based Study of Information, Motivation, and Behavioral Skills.

作者信息

Chien Tung-Chun Russell, Weng Shao-En, Hsu Wan-Tseng

机构信息

Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.

School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

Patient Prefer Adherence. 2025 Jun 26;19:1855-1868. doi: 10.2147/PPA.S527419. eCollection 2025.

DOI:10.2147/PPA.S527419
PMID:40599304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209603/
Abstract

BACKGROUND

Heart failure (HF) remains a major global health challenge. Guideline-directed medical therapy can effectively reduce mortality and hospitalizations; however, persistent medication nonadherence hinders its real-world impact. Although recent guidelines emphasize the pivotal role of pharmacists in supporting medication adherence, the mechanisms through which pharmacist-led patient education influences medication adherence remain underexplored. Identifying these mechanisms could inform the development of evidence-based strategies to optimize medication adherence and ultimately improve long-term outcomes in HF management.

OBJECTIVE

This study aims to establish an Information-Motivation-Behavioral Skills (IMB) model to elucidate the mechanisms influencing medication adherence among patients with HF and to compare pre- and postintervention models for identifying significant pathways affected by pharmacist-led patient education.

METHODS

In this longitudinal pretest-posttest study, all IMB constructs-information, personal motivation, social motivation, behavioral skills, and behavior-will be assessed using validated patient-reported outcome measures (PROMs) at baseline and three and six months postintervention; additionally, verbal inquiries will be conducted to evaluate the information construct and prescription refill data will be incorporated to supplement the behavior construct. Multigroup structural equation modeling will examine relationships among these constructs and their impact on medication adherence. Latent class growth modeling will also be employed to identify distinct adherence trajectory subgroups after six-month follow-up.

EXPECTED OUTCOMES

The recruitment phase commenced in early May 2025. By evaluating structural changes in IMB pathways pre- and postintervention using PROMs, followed by identifying short-term and sustained responders, the study is expected to facilitate the precise targeting of pharmacist-led interventions to maximize clinical impact. This approach emphasizes the importance of tailoring healthcare delivery to individual medication adherence profiles. It aims to ensure that pharmacist-led patient education achieves its fullest potential in populations expected to benefit the most, particularly patients with HF-a perspective that, to our knowledge, has not been previously explored.

摘要

背景

心力衰竭(HF)仍然是一项重大的全球健康挑战。指南指导的药物治疗可有效降低死亡率和住院率;然而,持续的用药不依从阻碍了其在现实世界中的效果。尽管近期指南强调了药剂师在支持用药依从性方面的关键作用,但药剂师主导的患者教育影响用药依从性的机制仍未得到充分探索。确定这些机制可为制定基于证据的策略提供依据,以优化用药依从性并最终改善心力衰竭管理的长期结果。

目的

本研究旨在建立信息-动机-行为技能(IMB)模型,以阐明影响心力衰竭患者用药依从性的机制,并比较干预前后的模型,以确定受药剂师主导的患者教育影响的重要途径。

方法

在这项纵向的干预前-干预后研究中,所有IMB构建要素——信息、个人动机、社会动机、行为技能和行为——将在基线以及干预后3个月和6个月使用经过验证的患者报告结局测量指标(PROMs)进行评估;此外,将进行口头询问以评估信息构建要素,并纳入处方 refill 数据以补充行为构建要素。多组结构方程模型将检验这些构建要素之间的关系及其对用药依从性的影响。潜在类别增长模型也将用于在6个月随访后识别不同的依从轨迹亚组。

预期结果

招募阶段于2025年5月初开始。通过使用PROMs评估干预前后IMB途径的结构变化,然后识别短期和持续反应者,预计该研究将有助于精准定位药剂师主导的干预措施,以最大化临床影响。这种方法强调了根据个体用药依从性概况调整医疗服务的重要性。其目的是确保药剂师主导的患者教育在预期受益最大的人群中发挥最大潜力,特别是心力衰竭患者——据我们所知,这一观点此前尚未得到探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/54a95ba96740/PPA-19-1855-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/c2fadb7b1e00/PPA-19-1855-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/adb705009d3a/PPA-19-1855-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/54a95ba96740/PPA-19-1855-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/c2fadb7b1e00/PPA-19-1855-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/adb705009d3a/PPA-19-1855-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fce/12209603/54a95ba96740/PPA-19-1855-g0003.jpg

相似文献

1
Improving Medication Adherence in Heart Failure Through Pharmacist-Led Patient Education: Protocol for a Mechanism-Based Study of Information, Motivation, and Behavioral Skills.通过药剂师主导的患者教育提高心力衰竭患者的用药依从性:一项基于信息、动机和行为技能的机制性研究方案
Patient Prefer Adherence. 2025 Jun 26;19:1855-1868. doi: 10.2147/PPA.S527419. eCollection 2025.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Interventions to improve adherence to inhaled steroids for asthma.改善哮喘患者吸入性糖皮质激素依从性的干预措施。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD012226. doi: 10.1002/14651858.CD012226.pub2.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施,以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
9
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
10
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.

本文引用的文献

1
Patient satisfaction matters: Translation, cross-cultural adaptation, and validation of the modified Patient Satisfaction with Pharmacist Services Questionnaire into Traditional Chinese (C-mPSPSQ 2.0) among patients with heart failure.患者满意度至关重要:心力衰竭患者中改良版《药剂师服务患者满意度问卷》翻译成中文(C-mPSPSQ 2.0)、跨文化调适及验证。
Res Social Adm Pharm. 2025 Aug;21(8):559-572. doi: 10.1016/j.sapharm.2025.03.006. Epub 2025 Mar 6.
2
An interactive visualization dashboard for predicting the effect of sacubitril/valsartan initiation in patients with heart failure.用于预测沙库巴曲缬沙坦起始治疗对心力衰竭患者疗效的交互式可视化仪表板。
Comput Biol Med. 2025 Mar;186:109667. doi: 10.1016/j.compbiomed.2025.109667. Epub 2025 Jan 17.
3
Pharmacist-Led Management Model and Medication Adherence Among Patients With Chronic Heart Failure: A Randomized Clinical Trial.药剂师主导的管理模式与慢性心力衰竭患者的药物依从性:一项随机临床试验。
JAMA Netw Open. 2024 Dec 2;7(12):e2453976. doi: 10.1001/jamanetworkopen.2024.53976.
4
Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries With Heart Failure.医疗保险受益人心力衰竭患者中沙库巴曲缬沙坦依从性轨迹
JACC Adv. 2024 May 8;3(7):100958. doi: 10.1016/j.jacadv.2024.100958. eCollection 2024 Jul.
5
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.2024年美国心脏病学会降低射血分数心力衰竭治疗专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024. Epub 2024 Mar 8.
6
What is the association of polypharmacy with frailty in heart failure? A systematic review and meta-analysis.多重用药与心力衰竭患者衰弱之间有何关联?一项系统评价与荟萃分析。
J Frailty Sarcopenia Falls. 2024 Mar 1;9(1):51-65. doi: 10.22540/JFSF-09-051. eCollection 2024 Mar.
7
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
8
Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.弥合差距,优化心力衰竭指南导向的医学治疗的实施。
Prog Cardiovasc Dis. 2024 Jan-Feb;82:61-69. doi: 10.1016/j.pcad.2024.01.008. Epub 2024 Jan 18.
9
The Worsening Renal Perfusion Index Predicts the Prognoses of Heart Failure Patients Treated with Sacubitril/Valsartan.肾功能恶化指数预测沙库巴曲缬沙坦治疗心力衰竭患者的预后。
Cardiorenal Med. 2023;13(1):310-323. doi: 10.1159/000534095. Epub 2023 Sep 14.
10
Validation and adaption of an Information-Motivation-Behavioral Skills model of medication adherence in older patients with multimorbidity.验证和改编了一个针对患有多种疾病的老年患者药物依从性的信息-动机-行为技能模型。
Patient Educ Couns. 2023 Aug;113:107756. doi: 10.1016/j.pec.2023.107756. Epub 2023 Apr 14.